Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease

Abstract

Summary In a study of 207 SARS-CoV2-infected individuals with a range of severities followed over 12 weeks from symptom onset, we demonstrate that an early robust bystander CD8 T cell immune response, without systemic inflammation, is characteristic of asymptomatic or mild disease. Those presenting to hospital had delayed bystander responses and systemic inflammation already evident at around symptom onset. Such early evidence of inflammation suggests immunopathology may be inevitable in some individuals, or that preventative intervention might be needed before symptom onset. Viral load does not correlate with the development of this pathological response, but does with its subsequent severity. Immune recovery is complex, with profound persistent cellular abnormalities correlating with a change in the nature of the inflammatory response, where signatures characteristic of increased oxidative phosphorylation and reactive-oxygen species-associated inflammation replace those driven by TNF and IL-6. These late immunometabolic inflammatory changes and unresolved immune defects may have clinical implications.

Cited by papers we hold 6

• A review of cytokine-based pathophysiology of Long COVID symptoms · 2023
  No notice
• SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort · 2022
  Not checked
• Characteristics and impact of Long Covid: Findings from an online survey · 2022
  No notice
• COVID-19 therapeutics: Challenges and directions for the future · 2022
  No notice
• Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection · 2022
  No notice
• Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.